Physician
Santa Clara Family Clinic PLLC
Santa Clara Family Clinic PLLC was paid $2.63M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoSANTA CLARA FAMILY CLINIC PLLC
HOUSTON, TX 77087
HOUSTON, TX 77087
33aNPI1255761326assigned 11/26/2013
33bProvider typePediatrics Physician
28Total paid$2.63M
24GClaims97,908
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#181 of 1,136
Median peer was paid$329K
This provider vs. median8.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 232 | $6K | |
| 2019 | 676 | $7K | |
| 2020 | 5,255 | $117K | |
| 2021 | 22,508 | $571K | |
| 2022 | 27,987 | $772K | |
| 2023 | 23,269 | $698K | |
| 2024incomplete | 17,981 | $458K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 14,689 | 12,489 | $732K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 17,179 | 12,994 | $587K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.2% | 2,139 | 1,982 | $190K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.7% | 2,027 | 1,982 | $177K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.2% | 1,620 | 1,534 | $111K |
| 99000 | 4.2% | 10,947 | 10,196 | $109K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.6% | 7,080 | 3,268 | $96K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.2% | 8,144 | 3,145 | $85K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.2% | 1,035 | 1,011 | $84K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.2% | 6,050 | 4,108 | $83K |
| 99385 | 2.2% | 772 | 729 | $59K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 4,200 | 2,837 | $57K |
65 more codes
| 99204 | Doctor's office visit, new patient (more involved) | 2.0% | 609 | $53K |
| 92557 | <1% | 1,155 | $26K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 398 | $25K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 279 | $19K |
| 99091 | <1% | 124 | $19K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 225 | $17K |
| 99384 | <1% | 151 | $14K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,030 | $11K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 112 | $9K |
| 90620 | <1% | 203 | $7K | |
| 90461 | <1% | 1,367 | $6K | |
| 99350 | Prolong home eval add 15m | <1% | 68 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 510 | $5K |
| 81025 | <1% | 681 | $5K | |
| 90734 | <1% | 769 | $5K | |
| 87807 | <1% | 408 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,250 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 395 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 219 | $3K |
| 81002 | <1% | 855 | $2K | |
| 90686 | <1% | 657 | $2K | |
| 99491 | Ccm add 20min | <1% | 507 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 159 | $1K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 242 | $1K |
| 99337 | <1% | 297 | $1K | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 361 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 40 | $1K |
| 90651 | <1% | 502 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,338 | $846.73 |
| 99383 | <1% | 13 | $791.96 | |
| 90707 | <1% | 196 | $652.79 | |
| 90716 | <1% | 241 | $619.07 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 22 | $563.10 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 20 | $458.71 |
| 90715 | <1% | 226 | $363.63 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 255 | $342.06 |
| 99051 | <1% | 107 | $264.60 | |
| 90688 | <1% | 124 | $262.28 | |
| 86769 | <1% | 17 | $244.92 | |
| 90674 | <1% | 25 | $230.60 | |
| 3044F | <1% | 256 | $200.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $167.36 |
| 90700 | <1% | 666 | $161.70 | |
| 93000 | <1% | 12 | $139.29 | |
| 99490 | Ccm add 20min | <1% | 128 | $119.59 |
| 92558 | <1% | 15 | $110.85 | |
| 90672 | <1% | 35 | $80.33 | |
| 90713 | <1% | 512 | $39.51 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 26 | $10.81 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 13 | $1.93 |
| 90670 | 0% | 228 | $0.00 | |
| 90648 | 0% | 219 | $0.00 | |
| 90633 | 0% | 160 | $0.00 | |
| 99072 | 0% | 260 | $0.00 | |
| 90649 | 0% | 33 | $0.00 | |
| 3078F | 0% | 306 | $0.00 | |
| 99497 | 0% | 41 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 914 | $0.00 |
| 3074F | 0% | 425 | $0.00 | |
| 90744 | 0% | 24 | $0.00 | |
| 90680 | 0% | 40 | $0.00 | |
| 3008F | 0% | 427 | $0.00 | |
| 90657 | 0% | 31 | $0.00 | |
| 3017F | 0% | 13 | $0.00 | |
| 3079F | 0% | 73 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORA AMADOR, YULIET (CEO)
| Provider | Location | Paid |
|---|---|---|
| East Houston Family Practice PA | Houston, TX | $41K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.